Results 21 to 30 of about 31,781 (199)
Sporadic medullary thyroid carcinoma: clinical data from a university hospital
Clinics, 2009 INTRODUCTION: Medullary thyroid carcinoma may occur in a sporadic (s-medullary thyroid carcinoma, 75%) or in a multiple endocrine neoplasia type 2 form (MEN2, 25%).
Joya Emilie M. Correia-Deur +6 more
doaj +1 more source
Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma
Clinics, 2009 Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid carcinoma. Currently, calcitonin measurements are mostly useful in the evaluation of tumor size and progression, and as an index of biochemical improvement of medullary ...
Sergio PA Toledo +5 more
doaj +1 more source
Endocrinology Research and Practice, 2013 Coexistence of medullary thyroid carcinoma and primary hyperparathyroidism (PHPT) is well described, however, the association of non-medullary thyroid cancer and PHPT is less recognized.
Mehmet Aşık +5 more
doaj +1 more source
Medullary Carcinoma of the Thyroid
Cancer Control, 2000 Medullary thyroid cancer (MTC) is a distinct C-cell tumor of the thyroid. We review the oncogenesis and management of both sporadic tumors and those tumors arising as part of specific inherited syndromes. The RET proto-oncogene plays a role in the development of inherited forms of MTC and has become important in the clinical management of patients and ...
G W, Randolph, D, Maniar
openaire +2 more sources
Metachronous Follicular Variant of Papillary Thyroid Microcarcinoma in a Case of Medullary Carcinoma Thyroid [PDF]
Journal of Krishna Institute of Medical Sciences University, 2016 Medullary carcinoma and papillary thyroid carcinoma arise from the different cells. Simultaneous occurrence of both types is rare. Medullary carcinomas are characterised by calcitonin positivity.
Neelam Sood, Binit Kumar Khandelia
doaj
Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
BMC Endocrine Disorders, 2019 Background Medullary thyroid carcinoma is a neuroendocrine tumor belonging form a malignant growth of the thyroid parafollicular C-cells, representing from 1 to 10% of all thyroid cancer.
Claudio Gambardella +12 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2020 Purpose: To explore the clinical value of ultrasound in the diagnosis of medullary thyroid carcinoma by comparing with enhanced computed tomography. Methods: This retrospective study was performed on 62 patients with pathologically confirmed medullary ...
Liang Wang MD +5 more
doaj +1 more source
Case Reports in Endocrinology, 2014 Mixed medullary and follicular or papillary carcinoma of thyroid is an extremely rare tumor, characterized by coexistence of morphological and immunohistochemical features of both medullary carcinoma and follicular (or papillary) carcinoma.
Doina Piciu, Andra Piciu
doaj +1 more source
RET codon 609 mutations: a contribution for better clinical managing
Clinics, 2012 Medullary thyroid carcinoma currently accounts for 5-8% of all thyroid cancers. The clinical course of this disease varies from extremely indolent tumors that can go unchanged for years to an extremely aggressive variant that is associated with a high ...
Caterina Mian +4 more
doaj +1 more source
BMC Endocrine Disorders, 2019 Background Medullary thyroid carcinoma is a malignant uncommon and aggressive tumour of the parafollicular C cells. In about 75% of cases it is sporadic while, in case of RET mutation, it is associated to multiple endocrine neoplasia type 2 (25% of cases)
Claudio Gambardella +11 more
doaj +1 more source